CHRS stock lower on FDA rejection of cancer therapy (NASDAQ:CHRS)
Grandbrothers/iStock Editorial by way of Getty Photos U.S.-based Coherus BioSciences (NASDAQ:CHRS) and Chinese language pharmaceutical firm Junshi Biosciences (OTCPK:SHJBF) introduced ...